Many Laboratories Lack Appropriate Reference Ranges for Children's Cardiac Troponin Tests
Survey findings highlight challenges in interpreting blood tests used to identify heart-muscle injury in children.
A survey reported that many laboratories testing children for cardiac troponin do not have pediatric-specific reference ranges, potentially complicating the interpretation of results in young patients.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Cardiac troponin is a protein released into the bloodstream when heart muscle cells are injured. It is widely used in adult medicine to help evaluate suspected heart attacks and other forms of cardiac injury. Children, however, are not simply smaller adults. Troponin concentrations and their interpretation can differ according to age, the assay used and the clinical situation. Applying inappropriate reference ranges may make it more difficult for healthcare professionals to distinguish abnormal results from values that require different interpretation in pediatric patients. A raised troponin level does not automatically mean a child has had a heart attack. It can occur in other conditions involving heart-muscle injury, including myocarditis and certain severe illnesses. The findings underline the need for laboratories and hospitals to use validated, assay-appropriate pediatric reference information and interpret test results alongside symptoms, examination findings and other investigations.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
